Trial intelligence / Profile preview

Aspirin administration timing in well-controlled hypertension

NCT00386529Phase 4Completed

Sponsor
Boryung
Start
Sep 2006
Primary completion
Jan 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of aspirin in hypertension (HTN), sponsored by Boryung. Started Sep 2006; status: completed.

02

Drugs

aspirin
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00386529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00386529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call